Cargando…
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug
Tuberculosis remains one of the leading causes of death from a single pathogen globally. It is estimated that 1/4 of the world’s population harbors latent tuberculosis, but only a 5–10% of patients will develop active disease. During latent infection, Mycobacterium tuberculosis can persist unaffecte...
Autores principales: | Mori, Giorgia, Orena, Beatrice Silvia, Chiarelli, Laurent R., Degiacomi, Giulia, Riabova, Olga, Sammartino, José Camilla, Makarov, Vadim, Riccardi, Giovanna, Pasca, Maria Rosalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052010/ https://www.ncbi.nlm.nih.gov/pubmed/32158439 http://dx.doi.org/10.3389/fmicb.2020.00292 |
Ejemplares similares
-
Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients
por: Degiacomi, Giulia, et al.
Publicado: (2019) -
New Drugs and Novel Cellular Targets against Tuberculosis
por: Degiacomi, Giulia, et al.
Publicado: (2022) -
Mechanochemical Synthesis and Biological Evaluation of Novel Isoniazid Derivatives with Potent Antitubercular Activity
por: Oliveira, Paulo F. M., et al.
Publicado: (2017) -
In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates
por: Degiacomi, Giulia, et al.
Publicado: (2020) -
CanB, a Druggable
Cellular Target in Mycobacterium tuberculosis
por: Degiacomi, Giulia, et al.
Publicado: (2023)